Abstract
Clinical variables readily available to clinicians at the time of presentation are considered in the development of inclusion and exclusion criteria. Initial risk stratification focuses on the prediction of acute inpatient mortality as the primary endpoint and on easily available parameters such as demographics, hemodynamics, comorbidities, and 12-lead electrocardiography (ECG). More recently, biomarkers have been included in risk stratification, specifically cardiac troponin (cTn), high-sensitivity cardiac troponin (hsTn), the natriuretic peptides (NP) B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP), and markers of acute kidney injury (AKI). Clinical variables for risk stratification for ADHF are often categorized broadly into demographics, cognitive function/social services, comorbidities, hemodynamics, cardiac ischemia markers, electrolytes, and heart failure biomarkers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed A, et al. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail. 2008;14:211.
Rosamond W, et al. Heart disease and stroke statistics–2008 updated: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25.
Abraham WT, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008;52:347.
Fonarow GC, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297:61.
O’Connor CM, et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2008;156:662.
Lee SL, et al. Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis. Circ Heart Fail. 2010;3:228–35.
Schrock JW, Emerman CL. Observation unit management of acute decompensated heart failure. Heart Fail Clin. 2009;5(1):85. vii.
Collins SP, et al. Cost-effectiveness analysis of ED decision making in patients with non-high-risk heart failure. Am J Emerg Med. 2009;27(3):293.
Fine MJ, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. NEJM. 1997;336(4):243.
Selker HP, et al. Use of the Acute Cardiac Ischemia Time-Insensitive Predictive Instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. Ann Intern Med. 1998;129(11):845.
Pollack Jr CV, et al. Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population. Acad Emerg Med. 2006;13(1):13–8.
Peacock WF, et al. Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient—parts 1–6. Acute Card Care. 2009;11(1):3–42.
Collins SP, et al. Low-risk acute heart failure patients: external validation of the Society of Chest Pain Center’s recommendations. Crit Pathw Cardiol. 2009;8(3):99–103.
McKee PA, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285(26):1441–6.
Felker GM, et al. Risk stratification after hospitalization for decompensated heart failure. J Card Fail. 2004;10(6):460–6.
Barsheshet A, et al. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med. 2006;166(15):1613–9.
Fermann GJ, Collins SP. Observation units in the management of acute heart failure syndromes. Curr Heart Fail Rep. 2010;7(3):125–33.
Selker HP, Griffith JL, D’Agostino RB. A time-insensitive predictive instrument for acute hospital mortality due to congestive heart failure: development, testing, and use for comparing hospitals: a multicenter study. Med Care. 1994;32(10):1040–52.
Fonarow GC, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293(5):572–80.
Gheorghiade M, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296(18):2217–26.
Vital FM, et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema. Cochrane Database Syst Rev. 2008;3:CD005351.
Masip J, et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary edema: a randomized trial. Lancet. 2000;356(9248):2126–32.
Mak S, et al. Effect of hyperoxia on left ventricular function and filling pressures in patients with and without congestive heart failure. Chest. 2001;120(2):467–73.
Formiga F, et al. Predictors of in-hospital mortality present at admission among patients hospitalised because of decompensated heart failure. Cardiology. 2007;108(2):73–8.
Szczech LA, et al. Acute kidney injury and cardiovascular outcomes in acute severe hypertension. Circulation. 2010;121(20):2183–91.
Damman K, et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart. 2010;96(16):1297–302.
Gheorghiade M, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28(8):980–8.
Peacock IV WF, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008;358:2117.
Diercks DB, et al. ED patients with heart failure: identification of an observational unit-appropriate cohort. Am J Emerg Med. 2006;24(3):319–24.
Maisel AS, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161–7.
McCullough PA, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106(4):416–22.
Maisel AS, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 2001;141(3):367–74.
Singer AJ, et al. Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): a randomized controlled trial of the effect of serial B-type natriuretic peptide testing on patient management. Circ Heart Fail. 2009;2(4):287–93.
Lokuge A, et al. B-type natriuretic peptide testing and the accuracy of heart failure diagnosis in the emergency department. Circ Heart Fail. 2010;3(1):104–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Fermann, G.J., Collins, S.P. (2012). Observation Unit Admission Inclusion and Exclusion Criteria. In: Peacock, W. (eds) Short Stay Management of Acute Heart Failure. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-627-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-61779-627-2_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-626-5
Online ISBN: 978-1-61779-627-2
eBook Packages: MedicineMedicine (R0)